126 related articles for article (PubMed ID: 30337562)
1. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.
Brooks HB; Meier TI; Geeganage S; Fales KR; Thrasher KJ; Konicek SA; Spencer CD; Thibodeaux S; Foreman RT; Hui YH; Roth KD; Qian YW; Wang T; Luo S; Torrado A; Si C; Toth JL; Mc Cowan JR; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Wang Y; Wu Z; Iversen PW; Njoroge FG
Sci Rep; 2018 Oct; 8(1):15458. PubMed ID: 30337562
[TBL] [Abstract][Full Text] [Related]
2. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.
Asby DJ; Cuda F; Beyaert M; Houghton FD; Cagampang FR; Tavassoli A
Chem Biol; 2015 Jul; 22(7):838-48. PubMed ID: 26144885
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model.
Fales KR; Njoroge FG; Brooks HB; Thibodeaux S; Torrado A; Si C; Toth JL; Mc Cowan JR; Roth KD; Thrasher KJ; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Margolis BJ; Wu Z; Wang Y; Atwell S; Wang J; Hui YH; Meier TI; Konicek SA; Geeganage S
J Med Chem; 2017 Dec; 60(23):9599-9616. PubMed ID: 29072452
[TBL] [Abstract][Full Text] [Related]
4. Identification of ATIC as a Novel Target for Chemoradiosensitization.
Liu X; Paila UD; Teraoka SN; Wright JA; Huang X; Quinlan AR; Gatti RA; Concannon P
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):162-173. PubMed ID: 29029884
[TBL] [Abstract][Full Text] [Related]
5. The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
Blood; 2009 Mar; 113(12):2776-90. PubMed ID: 18845790
[TBL] [Abstract][Full Text] [Related]
6. Structural analyses of a purine biosynthetic enzyme from Mycobacterium tuberculosis reveal a novel bound nucleotide.
Le Nours J; Bulloch EM; Zhang Z; Greenwood DR; Middleditch MJ; Dickson JM; Baker EN
J Biol Chem; 2011 Nov; 286(47):40706-16. PubMed ID: 21956117
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
Beckers A; Organe S; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; Brusselmans K; Verhoeven G; Swinnen JV
Mol Cancer Ther; 2006 Sep; 5(9):2211-7. PubMed ID: 16985054
[TBL] [Abstract][Full Text] [Related]
8. Substrate channelling by human IMP synthase.
Szabados E; Wilson PK; Christopherson RI
Adv Exp Med Biol; 1998; 431():241-4. PubMed ID: 9598067
[No Abstract] [Full Text] [Related]
9. A multisubstrate adduct inhibitor of AICAR transformylase.
Wall M; Shim JH; Benkovic SJ
J Med Chem; 1999 Sep; 42(18):3421-4. PubMed ID: 10479275
[No Abstract] [Full Text] [Related]
10. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
11. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) bifunctional enzyme from Candidatus Liberibacer asiaticus.
Lonare S; Rode S; Verma P; Verma S; Kaur H; Alam MS; Wangmo P; Kumar P; Roy P; Sharma AK
Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141015. PubMed ID: 38615986
[TBL] [Abstract][Full Text] [Related]
12. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis.
Wall M; Shim JH; Benkovic SJ
Biochemistry; 2000 Sep; 39(37):11303-11. PubMed ID: 10985775
[TBL] [Abstract][Full Text] [Related]
13. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis.
Verma P; Kar B; Varshney R; Roy P; Sharma AK
FEBS J; 2017 Dec; 284(24):4233-4261. PubMed ID: 29063699
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
15. Analysis of substrate binding in individual active sites of bifunctional human ATIC.
Witkowska D; Cox HL; Hall TC; Wildsmith GC; Machin DC; Webb ME
Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):254-263. PubMed ID: 29042184
[TBL] [Abstract][Full Text] [Related]
16. Structure and functional relationships in human pur H.
Beardsley GP; Rayl EA; Gunn K; Moroson BA; Seow H; Anderson KS; Vergis J; Fleming K; Worland S; Condon B; Davies J
Adv Exp Med Biol; 1998; 431():221-6. PubMed ID: 9598063
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.
Baggott JE; Vaughn WH; Hudson BB
Biochem J; 1986 May; 236(1):193-200. PubMed ID: 2431676
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.
Kimoloi S
Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763
[TBL] [Abstract][Full Text] [Related]
19. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
Marie S; Heron B; Bitoun P; Timmerman T; Van Den Berghe G; Vincent MF
Am J Hum Genet; 2004 Jun; 74(6):1276-81. PubMed ID: 15114530
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.
Wolan DW; Cheong CG; Greasley SE; Wilson IA
Biochemistry; 2004 Feb; 43(5):1171-83. PubMed ID: 14756553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
